Background and Purpose-Although the motor deficit after stroke is clearly due to the structural brain damage that has been sustained, this relationship is attenuated from the acute to chronic phases. We investigated the possibility that motor impairment and response to constraint-induced movement therapy in patients with chronic stroke may relate more strongly to the structural integrity of brain structures remote from the lesion than to measures of overt tissue damage. Methods-Voxel-based morphometry analysis was performed on MRI scans from 80 patients with chronic stroke to investigate whether variations in gray matter density were correlated with extent of residual motor impairment or with constraint-induced movement therapy-induced motor recovery. Results-Decreased gray matter density in noninfarcted motor regions was significantly correlated with magnitude of residual motor deficit. In addition, reduced gray matter density in multiple remote brain regions predicted a lesser extent of motor improvement from constraint-induced movement therapy. Conclusions-Atrophy in seemingly healthy parts of the brain that are distant from the infarct accounts for at least a portion of the sustained motor deficit in chronic stroke. (Stroke. 2012;43:00-00.)
T he deficit after stroke is clearly due to the brain damage that has been sustained as a result of ischemia or hemorrhage. However, there appears to be a decline in the influence of stroke lesion characteristics on severity of the motor deficit over the course of the first year poststroke. 1 Although most studies in acute stroke report weak to moderate relationships between motor deficit and lesion volume, [2] [3] [4] these relationships are largely absent in chronic stroke. 5 To our knowledge, the only consistently replicated predictor of residual motor deficit in chronic stroke is lesion location at the intersection of the corona radiata and fibers from the corpus callosum. 6, 7 The extent to which lesions interfere with descending pyramidal fibers has also been shown to predict prolonged motor deficit, 8, 9 albeit with exceptions. 10 Given that a substantial proportion of the variability in motor deficit cannot be accounted for by lesion factors alone, particularly among patients with chronic stroke with lesions outside the aforementioned regions, we postulated that diminished structural integrity of brain structures remote from the lesion might contribute importantly to the sustained motor deficit.
There is some evidence to support this conjecture. Brain metabolism of intact regions is often decreased in chronic stroke and the extent of this decrement has been associated with poorer motor recovery. [11] [12] [13] Furthermore, previous research has found that in chronic stroke, there may be significant bilateral diffuse structural loss in brain areas that are anatomically remote from the infarction. 14 -16 However, no study to date has systematically evaluated whether such changes may be correlated in chronic stroke with the amount of motor deficit or with changes in functional status. Accordingly, in this experiment, we evaluated whether chronic motor deficits in stroke are related to the amount of thinning in normal-appearing brain regions on MRI. We used voxelbased morphometry (VBM) to relate gray matter density (in brain areas without visible damage) to motor status of the paretic arm. In addition, we assessed the related question of whether regional gray matter thinning in patients with chronic stroke before treatment is related to the magnitude of improvement in motor status after constraint-induced movement (CI) therapy. 17 
Methods

Participants
Eighty-five patients with chronic stroke with mild to moderate motor deficit were enrolled in 1 of several studies examining their response to CI therapy or alternative motor interventions from 1997 to 2009.
The studies were performed at the University of Alabama at Birmingham, whose Institutional Review Board approved this research. All patients provided signed informed consent. Inclusion criteria consisted of poststroke interval of Ͼ10 months, ability to extend at least 20°at the wrist and 10°at each of the metacarpophalangeal joints, substantial nonuse of the more-affected arm (ie, score Յ2.5 out of 5 on the Motor Activity Log), general medical stability, ability to follow directions from project therapists, absence of current pharmacological treatment of their motor disability (eg, botulinum toxin), and no history of treatment with CI therapy.
Patients who met these criteria and who were medically cleared for MRI received volumetric T1-weighted MRI of their brain during the week preceding therapy. The most recent patients (nϭ49) were scanned on a Phillips (Intera) 3-Tesla machine and less recent patients on either a Philips (ACS) 1.5-Tesla machine (nϭ14) or a GE (Signa) 1.5-Tesla machine (nϭ17). For 80 patients (40 women), scans were of sufficient quality to be included in the current study. Patients ranged in age from 38 to 87 years (mean, 62.9Ϯ12.3 years). Stroke onset was 4.3Ϯ4.0 years previously. Thirty-nine exhibited right hemiparesis; 71 were right-handed before stroke. See the Table for a breakdown of patient characteristics.
Assessment of Pretreatment Motor Functioning
Motor functioning was assessed before and after treatment with the Motor Activity Log (MAL) and the Wolf Motor Function Test (WMFT), both of which have an established reliability and validity. The MAL quantifies how well and how often activities of daily living are carried out spontaneously by patients with their moreaffected arm outside the laboratory. 18, 19 The WMFT measures how rapidly patients perform standardized tests that they are required to carry out with the more-affected arm in the laboratory. 20, 21 The 2 measures thus assess different domains of motor ability; the MAL measures amount of spontaneous, real-world use of the more affected arm, whereas the WMFT measures capacity for carrying out standardized motor tasks with the more-affected arm on request in the laboratory. There is often a large difference between the 2 measures. 22, 23 Performance time on the WMFT was recorded as a log 2 transformation of the mean time in seconds to more accurately portray patient progress. 5
Interventions
Forty-four of 80 patients were randomly assigned to receive CI therapy, a motor rehabilitation therapy with proven efficacy for treating hemiparesis in chronic stroke. 17, 24, 25 The other 36 patients received comparison interventions or attenuated forms of CI therapy. Only those patients assigned to CI therapy (nϭ44), the most effective intervention, were retained for the analysis examining gray matter predictors of therapy outcome. The demographics of those receiving CI therapy were similar to those of the entire sample. Patients receiving CI therapy had a mean age of 62.1Ϯ12.2 years and mean stroke chronicity of 4.3Ϯ3.9 years; 23 were women, 22 exhibited right hemiparesis, and 41 were right-handed before stroke.
MRI Analysis
Noisier scans, largely those obtained on the older scanners, were initially processed through a modified version of the noise reduction approach devised by Placidi and colleagues. 26 A modified version of the Contourlet Hidden Markov Tree toolbox (Version 1.0) by Minh Do (http://www.ifp.uiuc.edu/Ϸminhdo/software/) was modified in Matlab 7.5 for this purpose. Scans were then corrected for radiofrequency inhomogeneity using the Statistical Parametric Mapping toolbox (SPM5, Wellcome Department of Cognitive Neurology, http://www.fil.ion.ucl.ac.uk/spm). Skull-stripping was performed using an in-house program to prevent extrabrain voxels from being classified as gray matter. Images were equated for deficit side by flipping left to right the brains of patients with right arm hemiparesis. Magnetic artifacts and focal structural change (eg, infarcts, periinfarcts) were masked through manual tracing using MRIcro/MRIcron software and refined using a semiautomated intensity thresholding technique. These tracings served as exclusion masks during (1) segmentation and normalization of the brain to prevent damaged tissue from affecting the algorithm; and (2) statistical analysis such that only remaining brain that was visibly spared from ischemia was analyzed.
VBM involves voxelwise comparisons of local gray matter density or volume. 27 Each patient's pretreatment brain scan underwent a procedure of joint normalization (to standard space) and segmentation (into gray matter, white matter, and cerebrospinal fluid) using SPM5 software. Brains were normalized to custom older adult templates 28 that were rendered symmetrical by averaging the original templates with their mirror image. Tracings of damaged tissue were then normalized using an identical transformation to create normalized masks of abnormal tissue. These regions of abnormal tissue were removed from each patient's gray matter image before smoothing. Finally, images were smoothed using a 10-mm Gaussian kernel to suppress noise and effects due to residual differences in gyral anatomy. The VBM processing steps are depicted in Supplemental Figure I (http://stroke.ahajournals.org).
Statistical Analysis
To determine whether a patient's motor status at pretreatment was related to the extent of atrophy, separate voxelwise multiple regressions were performed correlating gray matter density with MAL and WMFT scores, respectively (nϭ80). Confounding factors that could relate to gray matter density (scanner strength, age, peri-infarct volume, chronicity, and cortical versus subcortical lesion classification) were covaried out of the model. Voxelwise multiple regression analyses were similarly conducted to examine whether gray matter density predicts treatment outcome from CI therapy (nϭ44). Beta coefficient t statistics for motor status/outcome were initially thresholded at ␣ uncorrected ϭ0.05 (tϭϮ1.99 and tϭϮ2.02, respectively). SPM5 software was used to perform 2-tailed clusterwise statistics, corrected for familywise error (FWE), on each cluster of voxels exceeding this threshold. 29 
Results
Extent of Atrophy Correlates With Amount of Motor Deficit Pretreatment
Lower scores on the MAL were associated with reduced gray matter density in motor and motor-associated areas contralateral and ipsilateral to the motor deficit (cluster sizesϭ54 373 voxels and 49 939 voxels, respectively, Ps FWEcorrected Ͻ0.0001) and in the insula/temporal lobe ipsilateral to the motor deficit (cluster sizeϭ22 350 voxels, P FWEcorrected ϭ0.012). Longer performance times on the WMFT (ie, greater impairment) were correlated with reduced gray matter density in motor areas contralateral to the motor deficit (cluster sizeϭ93 428 voxels, P FWEcorrected Ͻ0.0001), to a lesser extent in ipsilateral motor areas, and in the thalamus, hippocampus, and insula ipsilateral to the more-affected arm (cluster sizeϭ45 316 voxels, P FWEcorrected Ͻ0.0001). The Figure A -B displays spatial maps of suprathreshold clusters for the MAL and WMFT. To ensure that the subjects who received CI therapy were representative of the total sample, statistical analyses were repeated on this subsample of patients (nϭ44). Nearly identical correlations were found between gray matter density and both MAL and WMFT pretreatment scores with only 1 major difference: the spatial extent of the MAL findings was diminished for the premotor and supplementary motor areas in the less affected hemisphere, likely due to reduced power to detect an effect.
Extent of Atrophy Correlates With Motor Gains After CI Therapy
Reduced gray matter density in the primary motor cortex contralateral to the more-affected extremity (cluster sizeϭ17 531 voxels, P FWEcorrected ϭ0.037) and greater gray matter density in posterior temporal-lateral occipital cortex contralateral to the deficit (cluster sizeϭ31 896 voxels, P FWEcorrected ϭ0.001) predicted less improvement on the MAL after CI therapy ( Figure C) . Less improvement on the WMFT after CI therapy (ie, greater time scores) was predicted by reduced gray matter density in several brain regions, including (1) bilateral cerebral peduncles, pons, medulla, and cerebellum contralateral to the more-affected arm, contralateral anterior temporal lobe (cluster sizeϭ73 292 voxels, P FWEcorrected Ͻ0.0001); (2) contralateral supplementary motor cortex and premotor cortex (cluster sizeϭ16 577 voxels, P FWEcorrected ϭ0.05); and (3) temporaloccipital region (motion processing area) of the hemisphere ipsilateral to the motor deficit (cluster sizeϭ17 572 voxels, P FWEcorrected ϭ0.041; Figure D ).
Discussion
Decreased density of noninfarcted tissue that is seemingly healthy is correlated with poorer pretreatment motor status and reduced response to an efficacious rehabilitation therapy. This finding provides evidence that at least part of the origin of the motor deficit in patients with chronic stroke is the extent to which gray matter density in motor areas remote from an infarct is affected. Thus, the structural integrity of apparently healthy gray matter tissue in chronic stroke is fundamentally important to motor control and real-world spontaneous use of the paretic arm. The topography of this relationship differs somewhat between outcome measures and assessment occasion (ie, pretreatment deficit in motor ability [WMFT scores], pretreatment amount of spontaneous use of the more affected arm in the life situation [MAL scores], and amount of improvement produced by CI therapy in both WMFT and MAL scores). However, a consistent finding across measures is that residual reduced motor functioning and reduced motor response to CI therapy are correlated with decreased gray matter density in contralateral sensorimotor cortical areas. In the ipsilateral hemisphere, decreased gray matter density in sensorimotor areas also predicted less real-world moreaffected arm use at pretreatment (MAL score). Of note, these are the same brain regions in which gray matter increases correlated with improvements in real-world arm use from CI therapy. 30 Gray matter density in bilateral cerebral peduncles, pons, medulla, cerebellum, anterior motor areas (prefrontal and supplementary motor areas) and regions of the temporal lobes was positively correlated with CI therapy-induced improvement on a laboratory-based measure of motor function (WMFT). These areas represent a network of brain regions involved in motor function, visual motion processing, and cognitive function. In summary, the structural integrity of widely distributed brain structures in both hemispheres is associated with better spontaneous motor recovery and rehabilitation response. The topography of these findings is consistent with functional alterations 31 and suggests a distributed neural network of motor recovery in chronic stroke.
At least 2 potential processes may explain the correlation between gray matter density and motor function in chronic stroke: (1) greater gray matter atrophy in subjects with greater motor impairment; and (2) greater neuroplastic compensation in subjects exhibiting greater motor recovery. There is stronger support for the first mechanism. Longitudinal and large cross-sectional studies of the topographical structural changes after stroke in humans have indicated that widespread cortical atrophy occurs. 14 -16 A longitudinal study in animals also showed bilateral thinning of gray matter after simulated stroke in the same brain areas in which we observed a correlation between gray matter density and motor performance. 32 Furthermore, gross losses of gray matter are visible to the naked eye in scans from many cases in our data set (see Supplemental Figure II ). Such structural changes may reflect the consequences of transsynaptic physiological alterations remote from the site of the infarction, for example, diaschisis 33 and/or structural correlates of well-documented metabolic alterations in these areas. 11, 13 Evidence for a generally atrophic process does not preclude the possibility of selective increases in amount of gray matter after stroke that may mitigate postischemic atrophy and support motor recovery. 30, 34, 35 For example, increased functional activity has been observed in compensatory brain regions after chronic stroke 36, 37 and may be linked with increased cortical thickness in these areas. 36 Thus, selective neuroplastic compensation, possibly mediated by the amount of use of the impaired arm, 30 may counteract widespread atrophy and contribute to partial restoration of motor function in chronic stroke.
Our finding that greater spontaneous recovery of motor function and enhanced rehabilitation response are associated with gray matter density in areas distant from the infarct suggests that therapies aimed at preserving or improving the integrity of remaining tissue are critical for optimal motor recovery. Longitudinal studies should trace the trajectories of widespread atrophy and selective growth in brain tissue and their contribution to motor status from acute to chronic stroke. Improved understanding of factors that attenuate the observed atrophy will identify additional targets for therapeutic intervention.
